Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer

This study is ongoing, but not recruiting participants.

Study NCT00006198 Information provided by National Center for Research Resources (NCRR)

First Received: September 9, 2000 Last Updated: June 23, 2005 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Liver Cancer

Additional conditions recognized in this trial

Liver Neoplasms

More general conditions related to this trial

Interventions listed in this trial

thalidomide

Additional drug interventions recognized in this trial

Doxorubicin

More general drug interventions related to this trial

Sponsors listed in this trial